New prognostic tool helps leukaemia patients plan for cancer treatment
First validated prognostic score offers valuable insights for patients advised to ‘watch and wait’ A…
Browsing: Chronic Lymphocytic Leukaemia
Clive James raised awareness of leukaemia, part of his rich and valuable legacy
Ian Olver, University of Adelaide Clive James has left a valuable legacy of astute observation…
Prime Minister’s science prizes awarded for algebra expertise, anti-cancer research and excellence in science teaching
Michael Hopkin, The Conversation and Noor Gillani, The Conversation The 2019 Prime Minister’s Prize for…
Drug combo heralds major shift in chronic lymphocytic leukaemia treatment
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…
Hidden chemistry in flowers shown to kill cancer cells
Researchers at the University of Birmingham have shown that it’s possible to produce a compound…
EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed…
Patterns of chronic lymphocytic leukaemia growth identified
In patients with chronic lymphocytic leukaemia (CLL), the rate of disease growth is apt to…
Finding second hits to knock out leukaemia
Many new anti-cancer drugs inhibit proteins that are essential for the proliferation of cancer cells.…
New leukaemia drug is more effective and easier to use
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted…
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
A new study presented at ASH 2018 shows older patients with chronic lymphocytic leukaemia (CLL) have a…